Hepatitis B virus infection is associated with poor prognosis in patients with advanced non small cell lung cancer

Asian Pacific Journal of Cancer Prevention

Volumn 16, Issue 13, 2015, Pages 5285-5288

  Peng, Jie Wen ^a   Liu, Dong Ying ^a   Lin, Gui Nan ^a   Xiao, Jian jun ^a   Xia, Zhong Jun ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Hepatitis B surface antigen; Hepatitis B virus; Non small cell lung cancer; Prognosis; Survival

Indexed keywords

ADULT; AGED; CANCER STAGING; CHINA; COMPLICATION; FEMALE; FOLLOW UP; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LIVER TUMOR; LUNG TUMOR; MALE; MIDDLE AGED; MORTALITY; NON SMALL CELL LUNG CANCER; PATHOGENICITY; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SECONDARY; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; VIROLOGY;

ADULT; AGED; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CHINA; FEMALE; FOLLOW-UP STUDIES; HEPATITIS B; HEPATITIS B VIRUS; HUMANS; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE;

EID: 84939420757     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2015.16.13.5285     Document Type: Article

References (25)

1. Chen XQ, Peng JW, Lin GN, Li M, Xia ZJ (2012). The effect of prophylactic lamivudine on hepatitis B virus reactivation in HBsAg-positive patients with diffuse large B-cell lymphoma undergoing prolonged rituximab therapy. Med Oncol, 29, 1237-41.
2. De Mitri MS, Cassini R, Bernardi M (2010). Hepatitis B virus-related hepatocarcinogenesis: molecular oncogenic potential of clear or occult infections. Eur J Cancer, 46, 2178-86.
3. Deng W, Long L, Li JL, et al (2014). Mortality of major cancers in Guangxi, China: sex, age and geographical differences from 1971 and 2005. Asian Pac J Cancer Prev, 15, 1567-74.
4. Engels EA, Cho ER, Jee SH (2010). Hepatitis B virus infection and risk of non-Hodgkin lymphoma in South Korea: a cohort study. Lancet Oncol, 11, 827-34.
5. Hatanaka K, Kudo M, Fukunaga T, et al (2007). Clinical characteristics of NonBNonC-HCC: comparison with HBV and HCV related HCC. Intervirology, 50, 24-31.
6. Hoofnagle JH (2009). Reactivation of hepatitis B. Hepatology, 49, 156-65.
7. Jiang XF, Tang QL, Zou Y, et al (2014). Does HBV infection increase risk of endometrial carcinoma? Asian Pac J Cancer Prev, 15, 713-6.
8. Li L, Wu B, Yang LB, Yin GC, Liu JY (2013). Chronic hepatitis B virus infection and risk of pancreatic cancer: a meta-analysis. Asian Pac J Cancer Prev, 14, 275-9.
9. Li SL, Su M, Peng T, et al (2013). Clinicopathologic characteristics and prognoses for multicentric occurrence and intrahepatic metastasis in synchronous multinodular hepatocellular carcinoma patients. Asian Pac J Cancer Prev, 14, 217-23.
10. Lin GN, Peng JW, Xiao JJ, Liu DY, Xia ZJ (2014). Hepatitis B virus reactivation in hepatitis B surface antigen seropositive patients with metastatic non-small cell lung cancer receiving cytotoxic chemotherapy: the efficacy of preemptive lamivudine and identification of risk factors. Med Oncol, 31, 119.
11. Liu J, Yang XL, Li A, et al (2014). Epidemiological patterns of cancer incidence in southern China: based on 6 population-based cancer registries. Asian Pac J Cancer Prev, 15, 1471-5.
12. Lu FM, Li T, Liu S, Zhuang H (2010). Epidemiology and prevention of hepatitis B virus infection in China. J Viral Hepat, 17, 4-9.
13. Mason A, Wick M, White H, et al (1993). Hepatitis B virus replication in diverse cell types during chronic hepatitis B virus infection. Hepatology, 18, 781-9.
14. Qiu HB, Zhang LY, Zeng ZL, et al (2011). HBV infection decreases risk of liver metastasis in patients with colorectal cancer: a cohort study. World J Gastroenterol, 17, 804-8.
15. She J, Yang P, Hong Q, Bai C (2013). Lung cancer in China: challenges and interventions. Chest, 143, 1117-26.
16. Sun Z, Ming L, Zhu X, Lu J (2002). Prevention and control of hepatitis B in China. J Med Virol, 67, 447-50.
17. Song E, Chen J, Ou Q, et al (2001). Rare occurrence of metastatic colorectal cancers in livers with replicative hepatitis B infection. Am J Surg, 181, 529-33.
18. Srivatanakul P, Honjo S, Kittiwatanachot P, el al (2010). Hepatitis viruses and risk of cholangiocarcinoma in northeast Thailand. Asian Pac J Cancer Prev, 11, 985-8.
19. Tang Y, Sun LG, Liu CS, et al (2013). Clinical analysis of stages of HBV infection in 100 cases of lymphoma. Asian Pac J Cancer Prev, 14, 959-62.
20. Wei XL, Qiu MZ, Chen WW, et al (2013). The status of HBV infection influences metastatic pattern and survival in Chinese patients with pancreatic cancer. J Transl Med, 11, 249.
21. Wu C, Li F, Jiao SC (2012). Prognostic factors for survival of patients with extensive stage small cell lung cancer-a retrospective single institution analysis. Asian Pac J Cancer Prev, 13, 4959-62.
22. Xie WC, Chan MH, Mak KC, Chan WT, He M (2012). Trends in the incidence of 15 common cancers in Hong Kong, 1983-2008. Asian Pac J Cancer Prev, 13, 3911-6.
23. Yeo W, Johnson PJ (2006). Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy. Hepatology, 43, 209-20.
24. Zhao SM, Li HC, Lou H, et al (2001). High Prevalence of HBV in Tibet, China. Asian Pac J Cancer Prev, 2, 299-304.
25. Zhu F, Li HR, Du GN, Chen JH, Cai SR (2011). Chronic hepatitis B virus infection and pancreatic cancer: a case-control study in southern China. Asian Pac J Cancer Prev, 12, 1405-8.